http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04193827-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 1990-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2496a4f7b8cdd90d7e32f5f15aade28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f71041d760d03116907e2be31ea95312
publicationDate 1992-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04193827-A
titleOfInvention Treating agent for chronic myelogenous leukemia
abstract PURPOSE: To obtain the title treating agent having low toxicity and low accumulation of toxicity by continuous administration, comprising ubenimex or a salt thereof as an active ingredient. n CONSTITUTION: A treating agent for chronic myelogenous leukemia comprising N-[(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl(7)-(L)-leucine (ubenimex) or a salt thereof as an active ingredient. A dose of the compound is 5-500mg per adult daily in oral administration and 1-300mg in parenteral administration. Preferable, a patient is previously dosed with a treating agent for chronic myelogenous leukemia such as busulfan and, at a point of time when number of leukocytes is reduced to ≤10,000/μl, the treating agent has to be administered. The treating agent is especially effective at an early period of disease, and high and complete hematologic remission is obtained and cytogenetic remission is also observable in high ratio. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9700677-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6245813-B1
priorityDate 1990-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6916047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425487766

Total number of triples: 23.